The journal PharmacoEconomics recently published OHE’s study projecting medicines expenditure in the UK to 2015. The PPRS 2014 Heads of Agreement was announced on 6 November 2013, outlining the terms of the five-year deal between the pharmaceuctical industry and the government in the UK.
For the first time in the UK, the PPRS caps future growth in the NHS branded medicines bill, between 2014 and 2018. OHE’s model for projecting NHS medicines expenditure was an important tool used by the Association of the British Pharmaceutical Industry (ABPI) to produce its forecast for discussion with the Department of Health.
The extended model, to the end of 2018, used the same methodology as in the PharmacoEconomics article.
**As of 22 Jan 2014, this extended 2014-2018 analysis is available as OHE Research Paper 14/01, free for download from the OHE website: www.ohe.org**
O’Neill, P., Mestre-Ferrandiz, J., Puig-Peiro, R. and Sussex, J. (2013) Projecting expenditure on medicines in the UK NHS. PharmcoEconomics. 31(10), 933-957.
This journal article is a refinement of an OHE Research Paper available on the OHE website. O’Neill, P., Mestre-Ferrandiz, J., Puig-Peiro, R. and Sussex, J. (2013) Projecting expenditure on medicines in the NHS. Research Paper. 13/02. London: Office of Health Economics.